
Sign up to save your podcasts
Or


Dr. Courtney Young is a prominent figure in the field of biotechnology, known for her pioneering work in gene editing therapies for rare muscle diseases. She is the co-founder and CEO of MyoGene Bio, a biotech startup focused on developing CRISPR-based therapies, particularly for Duchenne Muscular Dystrophy (DMD), a severegenetic disorder with no current cure.
Dr. Ana Maria Moreno is the Founder and CEO of Navega Therapeutics, Inc., a biotechnology company developing innovative gene therapies for chronic pain and other conditions.
Exploring the Future of Personal Diagnostics with Dr. Lu Yin of Persperion Diagnostics
Bob McGriff and David Crean discuss the current conditions in Life Science industry financing and what to look for in the second half of 2024.
On this episode of the podcast Bob and David discuss the current state of the life science ecosystem through the halfway point of 2024, and they offer thoughts and analysis of what to expect for the remainder of this year.
On the podcast we discuss the latest in AI-driven drug development and disease prediction.
Founder @ Pitch Hackerz | Mentor @ Techstars Oakland & NYC | Helped Founders Raise $500M+
Dr. Tari Suprapto is recognized for her work in licensing, building, and managing strategic alliances, along with a robust technical background, highlighting her as a leader in bridging the gap between academic research and commercial applications. Tari took us through her journey and thoughts on paths to biotech innovation and the role of collaboration in today's market.
Ardy Arianpour, CEO and Co-Founder of Seqster, joined Bob and David as guest for the Episode. Ardy shared the founding story and his vision for how Seqster is tackling the fragmentation of healthcare data by connecting patients' disparate health information into a single, comprehensive, and actionable patient health record. Listeners will also hear Ardy’s advice to entrepreneurs looking to innovate in the healthcare technology space and what has been the most rewarding aspects of leading the company.
From the publisher's feed